Skip to main content
Journal cover image

Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes.

Publication ,  Journal Article
Wang, L; Wada, Y; Ballan, N; Schmeckpeper, J; Huang, J; Rau, CD; Wang, Y; Gepstein, L; Knollmann, BC
Published in: J Mol Cell Cardiol
December 2021

BACKGROUND: Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) have emerged as a promising tool for disease modeling and drug development. However, hiPSC-CMs remain functionally immature, which hinders their utility as a model of human cardiomyocytes. OBJECTIVE: To improve the electrophysiological maturation of hiPSC-CMs. METHODS AND RESULTS: On day 16 of cardiac differentiation, hiPSC-CMs were treated with 100 nmol/L triiodothyronine (T3) and 1 μmol/L Dexamethasone (Dex) or vehicle for 14 days. On day 30, vehicle- and T3 + Dex-treated hiPSC-CMs were dissociated and replated either as cell sheets or single cells. Optical mapping and patch-clamp technique were used to examine the electrophysiological properties of vehicle- and T3 + Dex-treated hiPSC-CMs. Compared to vehicle, T3 + Dex-treated hiPSC-CMs had a slower spontaneous beating rate, more hyperpolarized resting membrane potential, faster maximal upstroke velocity, and shorter action potential duration. Changes in spontaneous activity and action potential were mediated by decreased hyperpolarization-activated current (If) and increased inward rectifier potassium currents (IK1), sodium currents (INa), and the rapidly and slowly activating delayed rectifier potassium currents (IKr and IKs, respectively). Furthermore, T3 + Dex-treated hiPSC-CM cell sheets (hiPSC-CCSs) exhibited a faster conduction velocity and shorter action potential duration than the vehicle. Inhibition of IK1 by 100 μM BaCl2 significantly slowed conduction velocity and prolonged action potential duration in T3 + Dex-treated hiPSC-CCSs but had no effect in the vehicle group, demonstrating the importance of IK1 for conduction velocity and action potential duration. CONCLUSION: T3 + Dex treatment is an effective approach to rapidly enhance electrophysiological maturation of hiPSC-CMs.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Mol Cell Cardiol

DOI

EISSN

1095-8584

Publication Date

December 2021

Volume

161

Start / End Page

130 / 138

Location

England

Related Subject Headings

  • Triiodothyronine
  • Single-Cell Analysis
  • Potassium Channels
  • Myocytes, Cardiac
  • Induced Pluripotent Stem Cells
  • Humans
  • Gene Expression Regulation
  • Dexamethasone
  • Cells, Cultured
  • Cardiovascular System & Hematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Wang, L., Wada, Y., Ballan, N., Schmeckpeper, J., Huang, J., Rau, C. D., … Knollmann, B. C. (2021). Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes. J Mol Cell Cardiol, 161, 130–138. https://doi.org/10.1016/j.yjmcc.2021.08.005
Wang, Lili, Yuko Wada, Nimer Ballan, Jeffrey Schmeckpeper, Jijun Huang, Christoph Daniel Rau, Yibin Wang, Lior Gepstein, and Bjorn C. Knollmann. “Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes.J Mol Cell Cardiol 161 (December 2021): 130–38. https://doi.org/10.1016/j.yjmcc.2021.08.005.
Wang, Lili, et al. “Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes.J Mol Cell Cardiol, vol. 161, Dec. 2021, pp. 130–38. Pubmed, doi:10.1016/j.yjmcc.2021.08.005.
Wang L, Wada Y, Ballan N, Schmeckpeper J, Huang J, Rau CD, Wang Y, Gepstein L, Knollmann BC. Triiodothyronine and dexamethasone alter potassium channel expression and promote electrophysiological maturation of human-induced pluripotent stem cell-derived cardiomyocytes. J Mol Cell Cardiol. 2021 Dec;161:130–138.
Journal cover image

Published In

J Mol Cell Cardiol

DOI

EISSN

1095-8584

Publication Date

December 2021

Volume

161

Start / End Page

130 / 138

Location

England

Related Subject Headings

  • Triiodothyronine
  • Single-Cell Analysis
  • Potassium Channels
  • Myocytes, Cardiac
  • Induced Pluripotent Stem Cells
  • Humans
  • Gene Expression Regulation
  • Dexamethasone
  • Cells, Cultured
  • Cardiovascular System & Hematology